Diseases, Conditions, Syndromes

Revealing global barriers to curative hep C treatment access

Almost 90% of the 57 million people living with hepatitis C live in low- and middle-income countries, but only half of these countries currently provide curative treatments at an accessible cost, according to a study by UNSW ...

Diseases, Conditions, Syndromes

The ethical dilemmas of preventing the next pandemic

Could protecting one group of people from disease, and exposing another to it, be the best way to prevent as many deaths as possible and reduce the impact of a future pandemic? A study led by some La Trobe academics says ...

page 2 from 40